- Home
- MHK vs TFX Comparison
MHK vs TFX Comparison
Compare MHK & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- TFX
- Stock Information
- Founded
- MHK 1988
- TFX 1943
- Country
- MHK United States
- TFX United States
- Employees
- MHK N/A
- TFX N/A
- Industry
- MHK Home Furnishings
- TFX Medical/Dental Instruments
- Sector
- MHK Consumer Discretionary
- TFX Health Care
- Exchange
- MHK Nasdaq
- TFX Nasdaq
- Market Cap
- MHK 8.8B
- TFX 8.4B
- IPO Year
- MHK 1992
- TFX N/A
- Fundamental
- Price
- MHK $119.17
- TFX $178.17
- Analyst Decision
- MHK Buy
- TFX Buy
- Analyst Count
- MHK 13
- TFX 8
- Target Price
- MHK $159.23
- TFX $255.14
- AVG Volume (30 Days)
- MHK 739.4K
- TFX 499.0K
- Earning Date
- MHK 02-06-2025
- TFX 02-20-2025
- Dividend Yield
- MHK N/A
- TFX 0.76%
- EPS Growth
- MHK N/A
- TFX N/A
- EPS
- MHK 8.85
- TFX 5.03
- Revenue
- MHK $10,812,015,000.00
- TFX $3,025,824,000.00
- Revenue This Year
- MHK N/A
- TFX $4.52
- Revenue Next Year
- MHK $1.95
- TFX $4.86
- P/E Ratio
- MHK $13.47
- TFX $35.35
- Revenue Growth
- MHK N/A
- TFX 2.27
- 52 Week Low
- MHK $96.28
- TFX $171.69
- 52 Week High
- MHK $164.29
- TFX $256.85
- Technical
- Relative Strength Index (RSI)
- MHK 27.27
- TFX 34.88
- Support Level
- MHK $115.82
- TFX $171.69
- Resistance Level
- MHK $133.00
- TFX $188.87
- Average True Range (ATR)
- MHK 3.66
- TFX 4.78
- MACD
- MHK -1.20
- TFX 0.13
- Stochastic Oscillator
- MHK 15.64
- TFX 27.52
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.